NUTRA PHARMA CORP. Research and Development Expense
NUTRA PHARMA CORP. (NPHC) reported Research and Development Expense of $0 for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-05-20.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2013-05-20
- NUTRA PHARMA CORP. research and development expense for the quarter ending 2013-03-31 was $0.00, a 100.00% decline year-over-year.
- NUTRA PHARMA CORP. research and development expense for the quarter ending 2012-12-31 was $0.00, a 100.00% decline year-over-year.
- NUTRA PHARMA CORP. research and development expense for the quarter ending 2012-09-30 was $0.00, a 100.00% decline year-over-year.
- NUTRA PHARMA CORP. research and development expense for the quarter ending 2012-06-30 was $485.00, a 99.21% decline year-over-year.
- NUTRA PHARMA CORP. research and development expense for fiscal 2012 was $3.05K, a 96.65% decline from fiscal 2011.
- NUTRA PHARMA CORP. research and development expense for fiscal 2011 was $90.86K, a 52.62% decline from fiscal 2010.
- NUTRA PHARMA CORP. research and development expense for fiscal 2010 was $191.79K.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|---|
| 2013-03-31 | $0.00 10-Q · filed 2013-05-20 | $0.00 derived: sum of 2 quarters · filed 2013-05-20 | $0.00 derived: sum of 3 quarters · filed 2013-05-20 | $485.00 derived: sum of 4 quarters · filed 2013-05-20 | |
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2013-04-16 | $0.00 derived: sum of 2 quarters · filed 2013-04-16 | $485.00 derived: sum of 3 quarters · filed 2013-04-16 | $3.05K 10-K · filed 2013-04-16 | |
| 2012-09-30 | $0.00 10-Q/A · filed 2012-12-12 | $485.00 derived: sum of 2 quarters · filed 2012-12-12 | $3.05K 10-Q/A · filed 2012-12-12 | $6.71K derived: sum of 4 quarters · filed 2013-05-20 | |
| 2012-06-30 | $485.00 10-Q/A · filed 2012-12-07 | $3.05K 10-Q/A · filed 2012-12-07 | $6.71K derived: sum of 3 quarters · filed 2013-05-20 | $23.97K derived: sum of 4 quarters · filed 2013-05-20 | |
| 2012-03-31 | $2.60K 10-Q · filed 2013-05-20 | $2.56K 10-Q/A · filed 2012-11-28 | $6.23K derived: sum of 2 quarters · filed 2013-05-20 | $23.48K derived: sum of 3 quarters · filed 2013-05-20 | $84.95K derived: sum of 4 quarters · filed 2013-05-20 |
| 2011-12-31 | $3.63K derived: 10-K 12 month − 10-Q/A 9 month · filed 2013-04-16 | $20.88K derived: sum of 2 quarters · filed 2013-04-16 | $82.35K derived: sum of 3 quarters · filed 2013-04-16 | $90.86K 10-K · filed 2013-04-16 | |
| 2011-09-30 | $17.25K 10-Q/A · filed 2012-12-12 | $78.72K derived: sum of 2 quarters · filed 2012-12-12 | $87.24K 10-Q/A · filed 2012-12-12 | $104.22K derived: sum of 4 quarters · filed 2012-12-12 | |
| 2011-06-30 | $61.47K 10-Q/A · filed 2012-12-07 | $69.98K 10-Q/A · filed 2012-12-07 | $86.97K derived: sum of 3 quarters · filed 2012-12-07 | $104.52K derived: sum of 4 quarters · filed 2012-12-07 | |
| 2011-03-31 | $8.52K 10-Q/A · filed 2012-11-28 | $25.50K derived: sum of 2 quarters · filed 2012-11-28 | $43.05K derived: sum of 3 quarters · filed 2012-11-28 | $145.49K derived: sum of 4 quarters · filed 2012-11-28 | |
| 2010-12-31 | $16.98K derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-11-15 | $34.54K derived: sum of 2 quarters · filed 2012-11-15 | $136.97K derived: sum of 3 quarters · filed 2012-11-15 | $191.79K 10-K/A · filed 2012-11-15 | |
| 2010-09-30 | $17.55K 10-Q · filed 2011-11-15 | $119.99K derived: sum of 2 quarters · filed 2011-11-15 | $174.80K 10-Q · filed 2011-11-15 | ||
| 2010-06-30 | $102.44K 10-Q · filed 2011-08-15 | $157.25K 10-Q · filed 2011-08-15 |